Targeting the hemoglobin problem in sickle cell disease usin

A class of drugs used for their ability to stop tumor cells from dividing is now under study for their potential to reduce the pain and damage caused by sickle cell disease, investigators report.

Related Keywords

United States , Georgia , India , Spain , Turkey , Saudi Arabia , Greece , America , American , Francisj Tedesco , Abdullah Kutlar , Panobinostat Farydak , Emily Henderson , Au Medical Center , Journal Of The American Medical Association , Augusta University Health , National Heart , Drug Administration , Centers For Disease , College Of Georgia , Blood Institute , Blood Disorders , Medical College , Augusta University , Betty Pace , Distinguished Chair , Pediatric Hematology , Multicenter Study , Sickle Cell Anemia , American Medical Association , Latanya Bowman , Disease Control , Saharan Africa , Western Hemisphere , Central America , Cell , Hemoglobin , Sickle Cell Disease , Anemia , Baby , Flood , Blood Vessels , Drugs , Gene , Ene Expression , Genes , Enetic , Hematology , Life Expectancy , Ncology , Oxygen , Rain , Red Blood Cells , Humor ,